Bio-Rad Laboratories | BIO - Cash And Equivalent


Bio-Rad Laboratories reported $395.8M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Abbott USD 7.51B 560M Sep/2025
Agilent USD 1.79B 254M Sep/2025
Becton, Dickinson and Co. USD 641M 94M Sep/2025
Bio Techne USD 172.88M 27.92M Dec/2025
Bio-Rad Laboratories USD 395.8M 26.5M Sep/2025
Bruker USD 293.1M 201.1M Sep/2025
Charles River Laboratories USD 207.1M 24.27M Sep/2025
Danaher USD 4.62B 3.09B Dec/2025
Exact Sciences USD 789.04M 131.94M Sep/2025
General Electric Aerospace USD 12.39B 109M Dec/2025
Hologic USD 2.17B 208.5M Dec/2025
Illumina USD 934M 179M Jun/2025
IQVIA Holdings USD 1.81B 225M Sep/2025
Laboratory Of America USD 598.1M 49.2M Sep/2025
Merck USD 18.17B 10.16B Sep/2025
Mettler Toledo International USD 69.06M 7.24M Sep/2025
Myriad Genetics USD 145.4M 71M Sep/2025
Quest Diagnostics USD 432M 113M Sep/2025
Repligen USD 748.75M 39.89M Sep/2025
Revvity USD 931.39M 60.46M Sep/2025
Roche Holding CHF 7.55B 579M Jun/2025
Siemens EUR 14.64B 1.96B Jun/2025
Standard Biotools USD 129.42M 29.2M Sep/2025
Thermo Fisher Scientific USD 9.85B 7.87B Dec/2025
Tosoh JPY 133.1B 10.44B Sep/2025
Waters USD 459.12M 91.9M Sep/2025